Ad
related to: gilead stock pricesuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Gilead reported strong Q3 results and expects a consistent growth ... The stock is up nearly 6% Thursday, trading at more than $96 per share, compared to a market close price of $91.69 per share ...
Gilead is a member of the Nasdaq-100 and the S&P 100. Gilead was founded in 1987 under the name Oligogen by Michael L. Riordan. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs like Tamiflu and Vistide ...
For the past year, the share price of Gilead Sciences (NASDAQ:GILD) has been a flat-line. GILD stock is also down about 18% since its high set in July.Source: Shutterstock But on Thursday, the ...
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. ... So, it is worth exploring what lies ahead for the ...
For premium support please call: 800-290-4726 more ways to reach us
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks ...
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) traded lower by 4% on Thursday amid broad market weakness following a spike in U.S. coronavirus cases.Gilead's remdesivir is one of the most advanced ...
Ad
related to: gilead stock pricesuperstockscreener.com has been visited by 10K+ users in the past month